* Genprex Inc GNPX.OQ GNPX.O is expected to show no
change in
quarterly revenue when it reports results on March 31
(estimated) for the period ending December 31 2023
*
* LSEG's mean analyst estimate for Genprex Inc is for a
loss of
$3.93 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Genprex Inc
is
$165.00, above its last closing price of $2.98.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -4.40 -4.40 -5.20 Missed -18.2
Jun. 30 2023 -4.80 -6.00 Missed -25
Mar. 31 2023 -4.80 -4.80 -7.60 Missed -58.3
Dec. 31 2022 -5.20 -5.60 -6.00 Missed -7.1
Sep. -4.80 -4.80 -5.20 Missed -8.3
30 2022
Jun. 30 2022 -4.80 -4.40 Beat 8.3
Mar. 31 2022 -4.80 -4.80 -4.80 Met 0
Dec. 31 2021 -3.20 -3.80 -4.80 Missed -26.3
This summary was machine generated March 29 at 19:07 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)